Schaeffer's Top Stock Picks for '25

Why This Trio of Biotechs is Blasting Off

News has propelled KemPharm Inc (NASDAQ:KMPH), Onconova Therapeutics Inc (NASDAQ:ONTX), and Prima Biomed Ltd. (NASDAQ:PBMD) to enormous gains

Aug 14, 2015 at 1:25 PM
facebook X logo linkedin


While several biotechs are making notable moves lower, several others are sitting on impressive afternoon gains. Included among the outperformers are KemPharm Inc (NASDAQ:KMPH), Onconova Therapeutics Inc (NASDAQ:ONTX), and Prima Biomed Ltd. (NASDAQ:PBMD). Here's a quick look at the news driving these biotech stocks up the charts.

Last night, KMPH revealed encouraging data concerning its experimental abuse-resistant pain drug. This is apparently outweighing a massive earnings miss -- at least in the minds of brokerage firms, with three boosting their price targets on the drugmaker. As such, the security has soared 25.2% to trade at $21.33, and earlier hit a record high of $26.15.

Analysts have been bullish toward KemPharm Inc for a while now. In fact, 100% of analysts tracking the shares consider them a "buy" or better. Also, the stock's average 12-month price target of $24.25 stood at a 42.3% premium to last night's close.

Moving along, ONTX said it submitted its application to the FDA, seeking approval to launch a late-stage trial on its cancer treatment, rigosertib. The news has sent the shares to the moon, up over 34% at $2.66. Longer term, though, the stock remains about 19% south of its year-to-date breakeven mark.

Today's bull gap is bad news for short sellers. Onconova Therapeutics Inc's short-interest ratio of 9.60 indicates it would take nearly two weeks for short sellers to buy back their positions, at average daily volumes.

Finally, PBMD has exploded 44% higher to trade at $1.44, after the firm said it will receive a clinical milestones payment from Novartis AG (ADR) (NYSE:NVS), based on a research and licensing arrangement with the larger drugmaker. Even more impressive, PBMD has now more than doubled in 2015.

However, short sellers aren't convinced. Short interest on Prima Biomed Ltd. more than tripled during the last two reporting periods -- though, at the stock's typical trading levels, it would still take less than a day to cover these bearish bets.
 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?